Mr. Martin Doane reports

LEVIATHAN CANNABIS DEBUTS ON THE CSE 25 INDEX AND ANNOUNCES NEW STOCK OPTION GRANTS

Leviathan Cannabis Group Inc. was added to the CSE 25 Index at the close of trading on Friday, June 15, 2018. As a requirement for inclusion in the composite index, a company must fall within the top quartile of eligible securities listed on the Canadian Securities Exchange.

Martin J. Doane, chief executive officer of Leviathan, comments: "It is a major accomplishment at our early stage of development and we appreciate the recognition from the CSE. Both the board and management at Leviathan are committed to building a unique, world-class enterprise for our shareholders."

The CSE Composite Index is a broad indicator of market activity for the Canadian Securities Exchange. With approximately 75-per-cent coverage of all equities listed on the CSE, it is a uniquely positioned gauge of the Canadian small-cap market. The index provides a distinctly different risk/return profile than the broad Canadian equity market.

Stock option grants

Leviathan also announces that the board of directors, on June 19, 2018, approved the granting of stock options to certain officers, directors and consultants exercisable for up to three million common shares at $2 per share. The expiration date for this entire range of options is June 19, 2021.

About Leviathan Cannabis Group Inc.

Leviathan plans on executing a series of strategic acquisitions that extend across all vertical markets in Canada and internationally, to support the company's proprietary brand strategy. This global reach positions the company to be a leading multijurisdictional medical and recreational cannabis enterprise and one that brings together the best cannabis products, brands and expertise from Canada and around the world.

We seek Safe Harbor.